Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
Genmab
 | This article may require cleanup to meet Wikipedia's quality standards. The specific problem is: A mess of an article whose lede is a disaster. (May 2024) |
 | |
| Company type | Public |
|---|---|
| Nasdaq Copenhagen: GMAB Nasdaq: GMAB (ADR) OMX Copenhagen 25 component[1] | |
| Industry | Biotechnology |
| Founded | 1999 |
| Founder | Florian Schönharting[2][3][4] and Lisa Drakeman[5] |
| Headquarters | Copenhagen, Denmark |
Number of locations | 4 (2023)[6] |
Key people |
|
| Products | DARZALEX/ DARZALEX FASPRO EPKINLY/TEPKINLY Kesimpta RYBREVANT TALVEY TECVAYLI TEPEZZA Tivdak |
| Revenue | DKK 16.474 billion (2023)[6] |
| DKK 5.321 billion (2023)[6] | |
| DKK 4.352 billion (2023)[6] | |
Number of employees | 2,204 (2023)[6] |
| Website | Genmab.com |
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund.[7] The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, the Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, and Genmab K.K. in Tokyo, Japan. Genmab is listed on the Copenhagen Stock Exchange in Denmark,[8] with American depositary receipts traded on the NASDAQ in the US.[9]
- ^ "OMX Copenhagen 25 index info".
- ^ "Biotekstjerne spottede de gode forretninger". Berlingske. 20 October 2018. Retrieved 14 November 2020.
- ^ "Marketscreener". Marketscrenner. Marketscreener. Retrieved 14 November 2020.
- ^ "Forward Pharma Board Members". Forward Pharma. Retrieved 14 November 2020.
- ^ Cite error: The named reference
Life Science Leader 2019was invoked but never defined (see the help page). - ^ a b c d e f Cite error: The named reference
AR2023was invoked but never defined (see the help page). - ^ Form 8-K Current Report (Form 8-K). US Securities and Exchange Commission. March 5, 1999. Contacts. Retrieved 6 January 2020.
- ^ "GMAB, Genmab, (DK0010272202)" (Dynamic webpage). Nasdaq Nordic Ltd. Retrieved 9 March 2022.
Market: Nasdaq Copenhagen
- ^ "Genmab A/S ADS (GMAB)" (Dynamic webpage). Nasdaq Inc. Retrieved 9 March 2022.
Market: Nasdaq
Previous Page Next Page
